iShares Nasdaq Biotechnology Index Fund Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (69)

Latest Posts

About This Stock More About This Stock
Rayno Biopharma Portfolio Update
Article By: Rod Raynovich
Monday, February 20, 2017 11:00 PM EST
We have updated our biopharmaceuticals portfolio for the period ending February 17 2017. Large caps biopharma stocks have only begun to recover in 2017 after the 2016 earnings release.
In this article: BMY, RHHBY, IBB, BIIB, GILD, XBI, BLUE, FMI Also: AMGN, ABBV
Read
Medical Devices And Healthcare Since He (Trump) Said "Pharma"
Article By: Gary Tanashian
Monday, February 20, 2017 1:42 PM EST
I’ve taken profits on the overbought IHI along with components BSX and WAT, while still holding MDT for a possible gap fill and date with the SMA 200.
In this article: BSX, CRY, MDT, WAT, IBB, AMGN, IHI, XLV
Read
This Biotech ETF Looks Primed To Rally Again
Article By: David Dierking
Monday, February 20, 2017 12:20 PM EST
The biotech sector has gotten a lot of attention lately both in the financial markets and in Washington.
In this article: IBB, XBI Also: BMY, NVS, PFE, RHHBY, ACAD, AMGN, GILD, BIIB, ILMN, CELG, VRTX
Read
Biotech And Health Care Stock Market Sector Showing Signs Of Life
Article By: Taki Tsaklanos
Thursday, February 16, 2017 5:43 PM EST
Biotechnology is now showing the first signs of life. The IBB ETF is up 3 percent on the week.
In this article: IBB, XLV
Read
Biotech Recap: Rally Continues With Strong Tape
Article By: Rod Raynovich
Thursday, February 16, 2017 11:55 AM EST
The best way to play the rally are these two ETFs–IBB and XBI because they have outperformed most large caps. If the sector remains strong then XBI should be favored because of small and mid-cap weightings.
In this article: IBB, XBI Also: BIIB, CLVS, GILD, TSRO, ALNY, ALXN, BMRN, INCY, SGEN, AMGN, ICPT
Read

PARTNER HEADLINES

Latest Tweets for $IBB

No tweets yet!